Cecilie Margaret Lander
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Cecilie Margaret Lander has a total of 117 co-authors. Here are the top co-authors by number of shared publications:
- Frank John Emery Vajda
Departments of Medicine and Neurosciences The Royal Melbourne Hospital, The University of Melbourne Parkville Victoria Australia
29 shared publications - Terence John O'BRien
Department of Neuroscience, School of Translational Medicine Monash University Melbourne Victoria Australia
22 shared publications - Janet E. Graham
Departments of Medicine and Neurosciences The Royal Melbourne Hospital, The University of Melbourne Parkville Victoria Australia
12 shared publications Mervyn J. Eadie
Royal Brisbane and Women's Hospital and School of Medicine and Biomedical Science, University of Queensland, Brisbane, QLD 4027, Australia
11 shared publications- Alison Hitchcock
Departments of Medicine and Neurosciences, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria 3050, Australia
8 shared publications J. Graham
Department of Medicine and Neurosciences, Royal Melbourne Hospital and University of Melbourne, Parkville, VIC 3050, Australia
8 shared publications
Latest Publications
- Open Access
- 25 April 2026
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 139, 33-37
Untreated epilepsy and pregnancy
- 25 April 2026
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 139, 33-37
Open AccessUntreated epilepsy and pregnancy
- Open Access
- 14 October 2025
- Published by Wiley in Epilepsia Open
- Vol. 10 (6) , 1892-1904
Progressive clonic slowing predicts severity of respiratory dysfunction and prolonged postictal immobility in tonic–clonic seizures
Objective: Progressive clonic slowing is a common electroclinical phenomenon observed during the clonic phase of bilateral tonic–clonic seizures (BTCS) and reflects an inhibitory phenomenon. We aimed to explore the relationship between progressive clonic slowing and biomarkers implicated in the pathophysiology of sudden unexpected death in epilepsy (SUDEP), specifically postictal immobility and respiratory dysfunction. Methods: We retrospectively reviewed video‐EEG data of 110 BTCS (24 females; median age 31.5 years) from 52 patients, evaluating the presence of progressive clonic slowing and durations of seizure phases, postictal immobility, and EEG suppression. Respiratory dysfunction was assessed using pulse oximetry data (available in 76 seizures), measuring the extent and duration of oxygen desaturation during and after seizures. Results: The presence of progressive clonic slowing was associated with greater oxygen desaturation (median extent of desaturation: 18.3% vs. 7.8%; p = 0.01) and longer duration of postictal immobility (median: 48.0 s vs. 20.5 s; p < 0.001). The absence of progressive clonic slowing strongly predicted that moderate to severe (negative predictive value [NPV]: 88.9%; p = 0.002) and severe desaturation (NPV: 100%; p = 0.027) would not occur. In BTCS with desaturation, the duration of postictal immobility was longer (23.0 s vs. 49.0 s; Mann–Whitney U , p < 0.001). While the presence of PGES was associated with both a higher likelihood and extent of desaturation, the median duration of PGES did not differ between groups with and without progressive clonic slowing. No independent association between progressive clonic slowing and PGES duration was identified. Significance: Progressive clonic slowing is an electroclinical marker associated with prolonged postictal immobility and oxygen desaturation. Shared mechanisms underlying progressive clonic slowing and postictal immobility may contribute to SUDEP pathophysiology. Recognition of progressive clonic slowing as a seizure severity marker may have important implications for SUDEP risk assessment and prevention strategies. Plain Language Summary: This study found that during some convulsive seizures, the jerking movements of the body slow down gradually before the seizure ends. This pattern, called progressive clonic slowing, was linked to more severe breathing problems and longer periods of immobility afterward. Recognizing this pattern may help doctors identify seizures that carry higher risks and guide efforts to prevent sudden death in people with epilepsy.
- 14 October 2025
- Published by Wiley in Epilepsia Open
- Vol. 10 (6) , 1892-1904
Open AccessProgressive clonic slowing predicts severity of respiratory dysfunction and prolonged postictal immobility in tonic–clonic seizures
Objective: Progressive clonic slowing is a common electroclinical phenomenon observed during the clonic phase of bilateral tonic–clonic seizures (BTCS) and reflects an inhibitory phenomenon. We aimed to explore the relationship between progressive clonic slowing and biomarkers implicated in the pathophysiology of sudden unexpected death in epilepsy (SUDEP), specifically postictal immobility and respiratory dysfunction. Methods: We retrospectively reviewed video‐EEG data of 110 BTCS (24 females; median age 31.5 years) from 52 patients, evaluating the presence of progressive clonic slowing and durations of seizure phases, postictal immobility, and EEG suppression. Respiratory dysfunction was assessed using pulse oximetry data (available in 76 seizures), measuring the extent and duration of oxygen desaturation during and after seizures. Results: The presence of progressive clonic slowing was associated with greater oxygen desaturation (median extent of desaturation: 18.3% vs. 7.8%; p = 0.01) and longer duration of postictal immobility (median: 48.0 s vs. 20.5 s; p < 0.001). The absence of progressive clonic slowing strongly predicted that moderate to severe (negative predictive value [NPV]: 88.9%; p = 0.002) and severe desaturation (NPV: 100%; p = 0.027) would not occur. In BTCS with desaturation, the duration of postictal immobility was longer (23.0 s vs. 49.0 s; Mann–Whitney U , p < 0.001). While the presence of PGES was associated with both a higher likelihood and extent of desaturation, the median duration of PGES did not differ between groups with and without progressive clonic slowing. No independent association between progressive clonic slowing and PGES duration was identified. Significance: Progressive clonic slowing is an electroclinical marker associated with prolonged postictal immobility and oxygen desaturation. Shared mechanisms underlying progressive clonic slowing and postictal immobility may contribute to SUDEP pathophysiology. Recognition of progressive clonic slowing as a seizure severity marker may have important implications for SUDEP risk assessment and prevention strategies. Plain Language Summary: This study found that during some convulsive seizures, the jerking movements of the body slow down gradually before the seizure ends. This pattern, called progressive clonic slowing, was linked to more severe breathing problems and longer periods of immobility afterward. Recognizing this pattern may help doctors identify seizures that carry higher risks and guide efforts to prevent sudden death in people with epilepsy.
- 26 April 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 169, 110441
The outcome of ceasing valproate before pregnancy in women with epilepsy
- 26 April 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 169, 110441
The outcome of ceasing valproate before pregnancy in women with epilepsy
- Open Access
- 4 March 2024
- Published by Elsevier in Epilepsy & Behavior
- Vol. 153, 109724
Pregnancy, antiseizure medications and unexplained intrauterine foetal death
- 4 March 2024
- Published by Elsevier in Epilepsy & Behavior
- Vol. 153, 109724
Open AccessPregnancy, antiseizure medications and unexplained intrauterine foetal death
- 2 March 2024
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 117, 198-201
Teratogenicity of zonisamide and other little-used antiseizure medications
- 2 March 2024
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 117, 198-201
Teratogenicity of zonisamide and other little-used antiseizure medications
- Open Access
- 13 October 2023
- Published by Elsevier in Epilepsy & Behavior
- Vol. 148, 109482
Changes over 24 years in a pregnancy register – Teratogenicity and epileptic seizure control
- 13 October 2023
- Published by Elsevier in Epilepsy & Behavior
- Vol. 148, 109482
Open AccessChanges over 24 years in a pregnancy register – Teratogenicity and epileptic seizure control
- Open Access
- 21 April 2023
- Published by Elsevier in Epilepsy & Behavior
- Vol. 142, 109219
Specific fetal malformations following intrauterine exposure to antiseizure medication
- 21 April 2023
- Published by Elsevier in Epilepsy & Behavior
- Vol. 142, 109219
Open AccessSpecific fetal malformations following intrauterine exposure to antiseizure medication
- 18 July 2022
- Published by Elsevier in Epilepsy & Behavior
- Vol. 134, 108848
Fetal malformations in successive pregnancies in Australian women with epilepsy
- 18 July 2022
- Published by Elsevier in Epilepsy & Behavior
- Vol. 134, 108848
Fetal malformations in successive pregnancies in Australian women with epilepsy
- 13 February 2022
- Published by Elsevier in Epilepsy & Behavior
- Vol. 129, 108602
Achieving neurologically desirable outcomes to pregnancy in women with epilepsy
- 13 February 2022
- Published by Elsevier in Epilepsy & Behavior
- Vol. 129, 108602
Achieving neurologically desirable outcomes to pregnancy in women with epilepsy
- 1 December 2021
- Published by Elsevier in Epilepsy & Behavior
- Vol. 125, 108406
The control of treated generalized and focal epilepsies during pregnancy
- 1 December 2021
- Published by Elsevier in Epilepsy & Behavior
- Vol. 125, 108406
The control of treated generalized and focal epilepsies during pregnancy